The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
Abstract We have previously shown that exon 1 of the huntingtin gene does not always splice to exon 2 resulting in the production of a small polyadenylated mRNA (HTTexon1) that encodes the highly pathogenic exon 1 HTT protein. The level of this read-through product is proportional to CAG repeat leng...
Guardado en:
Autores principales: | Andreas Neueder, Christian Landles, Rhia Ghosh, David Howland, Richard H. Myers, Richard L. M. Faull, Sarah J. Tabrizi, Gillian P. Bates |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/880697bfb72a45d88a4cbeba52640f2d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models
por: Michael A. Mason, et al.
Publicado: (2020) -
Regulatory mechanisms of incomplete huntingtin mRNA splicing
por: Andreas Neueder, et al.
Publicado: (2018) -
Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease.
por: Lara Moumné, et al.
Publicado: (2012) -
Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington’s disease
por: Jaisan Islam, et al.
Publicado: (2021) -
Hotspot exons are common targets of splicing perturbations
por: David T. Glidden, et al.
Publicado: (2021)